Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Gains from Investment Securities (2021 - 2025)

Kiniksa Pharmaceuticals International's Gains from Investment Securities history spans 5 years, with the latest figure at $53000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 99.41% year-over-year to $53000.0; the TTM value through Dec 2025 reached $2.0 million, down 72.06%, while the annual FY2025 figure was $727869.0, N/A changed from the prior year.
  • Gains from Investment Securities reached $53000.0 in Q4 2025 per KNSA's latest filing, down from $941874.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $11.6 million in Q3 2023 to a low of -$7.3 million in Q4 2022.
  • Average Gains from Investment Securities over 5 years is $2.2 million, with a median of $934718.5 recorded in 2024.
  • Peak YoY movement for Gains from Investment Securities: crashed 236.17% in 2022, then surged 5158.74% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $5.3 million in 2021, then plummeted by 236.17% to -$7.3 million in 2022, then soared by 103.61% to $262000.0 in 2023, then skyrocketed by 3332.82% to $9.0 million in 2024, then plummeted by 99.41% to $53000.0 in 2025.
  • Per Business Quant, the three most recent readings for KNSA's Gains from Investment Securities are $53000.0 (Q4 2025), $941874.0 (Q3 2025), and $576083.0 (Q2 2025).